Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-28

Clinical Trial Update: Enhancement of Connect to Protect® (C2P) [NA]

View source ↗

Summary

Clinical trial update on the Connect to Protect program for HIV infection; the UNC Chapel Hill-sponsored study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: HIV Infection | NA | Status: COMPLETED